We make a study of the influenza and COVID-19 epidemics in the USA (United States of America) for the seasons 2010/11 to 2024/25 for influenza and seasons 2020/21 to 2024/25 for COVID-19. For these, we use the data available from CDC (Centers for Disease Control and Prevention) related to Public Health Laboratory Virologic Age Surveillance and The Burden Estimates presented by CDC yearly.
References
[1]
Barberis, I., Myles, P., Ault, S.K., Bragazzi, N.L. and Martini, P. (2016) History and Evolution of Influenza Control through Vaccination: From the First Monovalent Vaccine to Universal Vaccines. Journal of Preventive Medicine and Hygiene, 57, E115-E120.
[2]
Hay, A.J., Gregory, V., Douglas, A.R. and Lin, Y.P. (2001) The Evolution of Human Influenza Viruses. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 356, 1861-1870. https://doi.org/10.1098/rstb.2001.0999
[3]
Van Tam, J. (1998) The Epidemiology of Influenza. In: Nicholson, K.G., Webster, R.G. and Hay, A.J., Eds., Textbook of Influenza, Blackwell Science, 181-206.
[4]
CDC (Centers for Disease Control and Prevention). https://www.cdc.gov/flu/about/viruses-types.html?CDC_AAref_Val= https://www.cdc.gov/flu/about/viruses/types.htm
[5]
CDC (Centers for Disease Control and Prevention). https://www.cdc.gov/flu/php/viruses/change.html?CDC_AAref_Val= https://www.cdc.gov/flu/about/viruses/change.htm
[6]
Treanor, J. (2004) Influenza Vaccine—Outmaneuvering Antigenic Shift and Drift. New England Journal of Medicine, 350, 218-220. https://doi.org/10.1056/nejmp038238
[7]
Webster, R.G., Bean, W.J., Gorman, O.T., Chambers, T.M. and Kawaoka, Y. (1992) Evolution and Ecology of Influenza a Viruses. Microbiological Reviews, 56, 152-179. https://doi.org/10.1128/mr.56.1.152-179.1992
[8]
Belongia, E.A., Skowronski, D.M., McLean, H.Q., Chambers, C., Sundaram, M.E. and De Serres, G. (2017) Repeated Annual Influenza Vaccination and Vaccine Effectiveness: Review of Evidence. Expert Review of Vaccines, 16, 723-736. https://doi.org/10.1080/14760584.2017.1334554
[9]
WHO (2025) Recommended Composition of Influenza Virus Vaccines for Use in the 2025-2026 Northern Hemisphere Influenza Season. https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2025-2026-nh-influenza-season
[10]
WHO (2024) Recommendations Announced for Influenza Vaccine Composition for the 2025 Southern Hemisphere Influenza Season. https://www.who.int/news/item/27-09-2024-recommendations-announced-for-influenza-vaccine-composition-for-the-2025-southern-hemisphere-influenza-season
[11]
Prompetchara, E., Ketloy, C. and Palaga, T. (2020) Immune Responses in COVID-19 and Potential Vaccines: Lessons Learned from SARS and MERS Epidemic. Asian Pacific Journal of Allergy and Immunology, 38, 1-9.
[12]
Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S.C. and Di Napoli, R. (2020) Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK554776/
[13]
Han, S., Yoon, A., Kim, M.J. and Yoon, J. (2022) What Influences Tourist Behaviors during and after the COVID-19 Pandemic? Focusing on Theories of Risk, Coping, and Resilience. Journal of Hospitality and Tourism Management, 50, 355-365. https://doi.org/10.1016/j.jhtm.2022.02.024
[14]
Kliger, D. (2021) Economic Behavior and Behavioral Economics at Times of COVID-19 Pandemic. Mind & Society, 20, 253-260. https://doi.org/10.1007/s11299-021-00280-6
[15]
Marin-Lopez, B.A., Jimenez-Gomez, D. and Abellán-Perpiñán, J. (2022) Behavioral Economics in the Epidemiology of the COVID-19 Pandemic: Theory and Simulations. International Journal of Environmental Research and Public Health, 19, Article No. 9557. https://doi.org/10.3390/ijerph19159557
[16]
Mori, T., Nagata, T., Ikegami, K., Hino, A., Tateishi, S., Tsuji, M., et al. (2022) Effect of COVID-19 Infection Related Experiences on Social Behaviors When a State of Emergency Is Declared: A Cohort Study. BMC Public Health, 22, Article No. 2445. https://doi.org/10.1186/s12889-022-14864-5
CDC (Centers for Disease Control and Prevention). Use of COVID-19 Vaccines in the United States. https://www.cdc.gov/vaccines/COVID-19/clinical-considerations/COVID-19-vaccines-us.html
[19]
Xie, Z., Hamadi, H.Y., Mainous, A.G. and Hong, Y. (2023) Association of Dual COVID-19 and Seasonal Influenza Vaccination with COVID-19 Infection and Disease Severity. Vaccine, 41, 875-878. https://doi.org/10.1016/j.vaccine.2022.12.043
[20]
CDC (Centers for Disease Control and Prevention). The Respiratory Virus Hospitalization Surveillance Network (RESP-NET). https://www.cdc.gov/resp-net/dashboard/
[21]
CDC (Centers for Disease Control and Prevention). Coronavirus Disease 2019 (COVID-19) Hospitalization Surveillance Network (COVID-NET). https://www.cdc.gov/covid/php/covid-net/index.html
[22]
CDC (Centers for Disease Control and Prevention). How CDC Estimates the Burden of COVID-19 in the US. https://www.cdc.gov/covid/php/surveillance/about-burden-estimates.html
[23]
CDC (Centers for Disease Control and Prevention). https://www.cdc.gov/flu/php/surveillance/in-season-severity.html
[24]
Soo, R.J.J., Chiew, C.J., Ma, S., Pung, R. and Lee, V. (2020) Decreased Influenza Incidence under COVID-19 Control Measures, Singapore. Emerging Infectious Diseases, 26, 1933-1935. https://doi.org/10.3201/eid2608.201229
[25]
Andreasen, V., Lin, J. and Levin, S.A. (1997) The Dynamics of Cocirculating Influenza Strains Conferring Partial Cross-Immunity. Journal of Mathematical Biology, 35, 825-842. https://doi.org/10.1007/s002850050079
[26]
Zinder, D., Bedford, T., Gupta, S. and Pascual, M. (2013) The Roles of Competition and Mutation in Shaping Antigenic and Genetic Diversity in Influenza. PLOS Pathogens, 9, e1003104. https://doi.org/10.1371/journal.ppat.1003104
[27]
Latorre-Margalef, N., Brown, J.D., Fojtik, A., Poulson, R.L., Carter, D., Franca, M., et al. (2017) Competition between Influenza a Virus Subtypes through Heterosubtypic Immunity Modulates Re-Infection and Antibody Dynamics in the Mallard Duck. PLOS Pathogens, 13, e1006419. https://doi.org/10.1371/journal.ppat.1006419
[28]
Wilasang, C., Suttirat, P., Chadsuthi, S., Wiratsudakul, A. and Modchang, C. (2022) Competitive Evolution of H1N1 and H3N2 Influenza Viruses in the United States: A Mathematical Modeling Study. Journal of Theoretical Biology, 555, Article ID: 111292. https://doi.org/10.1016/j.jtbi.2022.111292
[29]
Varshney, K., Pillay, P., Mustafa, A.D., Shen, D., Adalbert, J.R. and Mahmood, M.Q. (2023) A Systematic Review of the Clinical Characteristics of Influenza-COVID-19 Co-Infection. Clinical and Experimental Medicine, 23, 3265-3275. https://doi.org/10.1007/s10238-023-01116-y
[30]
Petersen, E., Koopmans, M., Go, U., Hamer, D.H., Petrosillo, N., Castelli, F., et al. (2020) Comparing SARS-CoV-2n with SARS-CoV and Influenza Pandemics. The Lancet Infectious Diseases, 20, e238-e244. https://doi.org/10.1016/s1473-3099(20)30484-9
